Pharm

Methylphenidate

search

Methylphenidate, Ritalin, Methylin, Concerta, Focalin, Metadate, Quillivant, Daytrana

  • Indications
  • Methylphenidate (Ritalin)
  1. Attention Deficit Hyperactivity Disorder (ADHD)
  2. Narcolepsy
  3. Depression in medically ill elderly patients
  4. Enhanced pain control in patients on Opiates
  • Contraindications
  • Mechanism
  1. See ADHD Medication
  2. As with other Amphetamine-like drugs, Methylphenidate triggers release of biogenic amines
    1. Norepinephrine, Dopamine and Serotonin are released from storage Vesicles
  3. Effects
    1. CNS Stimulation
      1. Inhibits fast-rate behavior in hyperkinetic, hyperactive children
      2. Speeds slow-rate behavior (e.g. improves memory and learning)
    2. Decreases appetite
    3. Ergogenic Aid in athletes (illicit use)
  • Precautions
  1. See ADHD Medication for overall approach and medication selection
  2. Maximum Dosing
    1. Adults and older adolescents (>50 kg) may in some cases need dosing in excess of listed maximum
    2. Exercise caution and Informed Consent as these doses are not FDA approved
      1. Exceed the manufacturers recommendation
    3. Absolute maximum doses
      1. Methylphenidate: 100 mg per day in divided doses
      2. Concerta 108 mg per day
    4. (2013) Presc Lett 20(9): 50-1
  • Pharmacokinetics
  • Methylphenidate
  1. Immediate Release: Ritalin-IR, Methylin IR
    1. Onset of action: within 20 to 30 minutes of dose (up to 60 minutes)
    2. Peaks at 1.9 hours on average
    3. Duration: 3 to 6 hours
  2. Immediate Release: Focalin (Dexmethylphenidate)
    1. D-isomer of Ritalin (l-isomer is inactive)
    2. Prescribed at half dose of Ritalin
    3. Same Pharmacokinetics as immediate release Methylphenidate
    4. Fewer Headaches but more Stomache pain than with Methylphenidate
  3. Long-Acting: Ritalin-LA
    1. Duration: 8 hours
    2. Biphasic release
      1. Immediate release: 50%
      2. Modified release beads: 50%
    3. Preferred over Ritalin SR
  4. Long-Acting: Ritalin-SR, Metadate ER, Methylin ER
    1. Onset of action: within 90 minutes of dose
    2. Peaks at 3 hours on average
    3. Duration: 5-8 hours (gradual decrease after 3 hours)
    4. Less effective than Ritalin IR twice daily
    5. Other sustained release forms are preferred
  5. Very-Long-Acting: Concerta
    1. Onset of action: within 60 to 120 minutes of dose
    2. Duration: 12 hours
    3. Comparable to Ritalin-IR three times daily
  6. Very-Long-Acting: Metadate-CD
    1. Flat concentration curve despite biphasic release
    2. Duration: 8-10 hours
    3. Biphasic peaks at 1.5 hours and again at 4.5 hours
      1. Immediate release beads: 30%
      2. Extended release beads: 70%
  7. Very-Long Acting: Quillivant XR
    1. Combination of Immediate release Methylphenidate (20%) and extended release Methylphenidate (80%)
    2. Peaks at 5 hours
    3. Duration: 12 hours
    4. Niche is that it is suspension (compounded by pharmacy) at 5 mg/ml
      1. Other stimulant capsules can be sprinkled on apple sauce (Focalin XR, Metadate CD, Ritalin LA, Adderall XR)
    5. References
      1. (2013) Presc Lett 20(2): 8-9
  • Dosing
  • Children (over age 6 years)
  1. Maximum total daily dose: 60 mg/day
  2. Immediate Release: Methylphenidate
    1. Usual Range: 0.5 - 1 mg/kg/day
    2. Start: 2.5 to 5 mg per dose, twice daily
    3. Initial Schedule (lasts 4 hours - dose up to 4 times daily)
      1. Morning: 2.5 to 5 mg PO 30 minutes before breakfast
      2. Noon: 2.5 to 5 mg PO 30 minutes before lunch
      3. Afternoon: 1.25 to 2.5 mg PO at 3-4 pm
    4. Titrate dose up weekly
      1. Increase dose by 0.1 mg/kg/dose (or 5-10 mg/day)
    5. Maximum dose: 2 mg/kg/day or 60 mg/day (some sources suggest maximum up to 90)
  3. Immediate Release: Focalin (Dexmethylphenidate)
    1. Start: 2.5 mg orally twice daily
    2. Usual Dose: 5-10 mg orally twice daily
    3. Maximum Dose: 20 mg orally daily
  4. Sustained Release
    1. Concerta 18 to 54 mg orally daily
      1. Start: 18 mg qAM
      2. May increase weekly by 18 mg/day
      3. Conversions
        1. Ritalin 5 mg or 20 mg SR: Concerta 18 mg
        2. Ritalin 10 mg or 40 mg SR: Concerta 36 mg
        3. Ritalin 15 mg or 60 mg SR: Concerta 54 mg
      4. Maximum: 72 mg/day
    2. Ritalin LA or Metadate CD
      1. Start: 20 mg orally daily
      2. May increase weekly by 10-20 mg/day
      3. Usual dose: 20-40 mg orally once daily
      4. Maximum: 60 mg/day
    3. Ritalin-SR (Other long-acting agents are preferred)
      1. Dose: 0.6 to 2 mg/kg up to 20-40 mg orally daily
      2. Dose is directly converted from Regular Ritalin
      3. Conversion to Ritalin SR (Metadate ER, Methylin ER)
      4. Administer cumulative 8 hour regular dose
      5. Example: Conversion
        1. Child takes Ritalin 10 mg, 5 mg, and 5 mg
        2. Ritalin SR dosing will be 20 mg qAM
      6. Example: Schedule
        1. Morning: 20-40 mg orally
        2. Early afternoon: 20 mg orally
    4. Daytrana (Methylphenidate patch)
      1. Start: 10 mg patch worn 9 hours daily
      2. Max: 30 mg patch worn 9 hours daily
      3. Skin irritation or rash may occur
  1. Maximum total daily dose: 90 mg
  2. Regular Release: 5 to 20 mg PO bid to tid at meals
  3. Sustained Release: 20 mg PO up to q8 hours
  • Dosing
  • Elderly with comorbid Depression
  1. Maximum total daily dose: 30 mg
  2. Regular Release: 5 to 10 mg bid to tid
  • Management Difficulty Swallowing Medication - Long Acting Methylphenidate
  1. Generic
    1. Ritalin LA
    2. Metadate CD Sprinkle caps
  2. Trade Name - Expensive ($300/month)
    1. Aptensio XR spinkle caps (lasts 12 hours)
    2. QuilliChew ER chewable 20 and 40 mg tabs (lasts 8-13 hours)
    3. Quillavant XR Suspension 5 mg/ml (lasts 12 hours)
    4. Adhansia XR (lasts 13 hours)
    5. Jornay PM (taken at night and peaks 14 hours later, the next morning)
    6. Contempla XR 17.3 mg dissolving tablets (lasts 12 hours)
    7. Daytrana Transdermal Patch 10 mg (lasts 10-12 hours)
  3. References
    1. (2016) Presc Lett 23(3):16
  • Drug Interactions
  1. Avoid concurrent Decongestant use
  2. Avoid within 14 days of MAO Inhibitor
  • Safety
  1. Pregnancy Category C
  2. Unknown safety in Lactation
  • Monitoring
  • Each Visit
  1. Height
  2. Weight
  3. Blood Pressure
  4. Pulse
  • Adverse Effects